NEW YORK CITY, NY / ACCESS Newswire / January 8, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zenas BioPharma, Inc. ("Zenas BioPharma" or "the Company") (NASDAQ:ZBIO). Investors who purchased Zenas BioPharma securities prior to September 13, 2024, and continue to hold to the present, are encouraged […]

NEW YORK CITY, NY / ACCESS Newswire / January 8, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV). Investors who purchased Elevance securities prior to April 18, 2024, and continue to hold to the present, are encouraged to obtain

NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sun Communities, Inc. ("Sun Communities" or "the Company") (NYSE:SUI). Investors who purchased Sun Communities securities prior to February 28, 2019, and continue to hold to the present, are encouraged to

NEW FREEDOM, Pa., Jan. 08, 2026 (GLOBE NEWSWIRE) — Nexterus, a world-class supply chain management and third-party logistics (3PL) services provider, and 4th generation family-owned & operated company, is celebrating its 80th year in business and has exciting personnel news to go along with the momentous company milestone. Nexterus is thrilled to share that Julia

Nexterus celebrates 80th anniversary, adds to executive team, and promotes from within GlobeNewswire January 08, 2026 NEW FREEDOM, Pa., Jan. 08, 2026 (GLOBE NEWSWIRE) — Nexterus, a world-class supply chain management and third-party logistics (3PL) services provider, and 4th generation family-owned & operated company, is celebrating its 80th year in business and has exciting personnel

NEW YORK CITY, NY / ACCESS Newswire / January 8, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CTO Realty Growth, Inc. ("CTO" or "the Company") (NYSE:CTO). Investors who purchased CTO securities prior to February 18, 2021, and continue to hold to the present, are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / January 8, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Corcept Therapeutics Incorporated ("Corcept" or "the Company") (NASDAQ:CORT). Investors who purchased Corcept securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CORT.

NEW YORK CITY, NY / ACCESS Newswire / January 8, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Danaher Corporation ("Danaher" or "the Company") (NYSE:DHR). Investors who purchased Danaher securities prior to April 21, 2022, and continue to hold to the present, are encouraged to obtain additional

(NASDAQ:SYNA), SAN JOSE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — Synaptics(R) Incorporated (Nasdaq: SYNA) today announced its participation in upcoming investor conference. Ken Rizvi, Chief Financial Officer, will present at the 28th Annual Needham Growth Conference on Tuesday, January 13, 2026 at 10:30 AM PT. To view the webcast or access a replay, please visit

Synaptics to Participate at Upcoming Investor Conference Tuesday, January 13, 2026 GlobeNewswire January 08, 2026 SAN JOSE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — Synaptics(R) Incorporated (Nasdaq: SYNA) today announced its participation in upcoming investor conference. Ken Rizvi, Chief Financial Officer, will present at the 28th Annual Needham Growth Conference on Tuesday, January 13, 2026